

Z100159 · 1.0 mg 20 ug
abm good · Cat: Z100159
Reach 3+ verified distributors
Manufacturer product page
abmgood.com/recombinant-human-aimp1-z100159.html
Description
EMAP-II is activated during apoptosis by cleavage of pro-EMAP through caspase 8 and enhances the recruitment of inflammatory cells by its chemotactic properties. Besides its chemotactic effect on inflammatory cells, EMAP-II increases the adhesiveness of coronary artery smooth muscle cells CASMC for monocytes. EMAP-II also has anti-angiogenic properties, which are explained by its pro-apoptotic effect on endothelial cells.







